NCT03362853View on ClinicalTrials.gov

A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 25, 2012

Primary Completion Date

August 10, 2012

Study Completion Date

August 10, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Nemonoxacin 500Mg Capsule

Receive a single dose in a fasting state

DRUG

Moxifloxacin 400Mg Tablet

Receive a single dose in a fasting state

DRUG

Nemonoxacin 750Mg Capsule

Receive a single dose in a fasting state

DRUG

Placebo oral capsule

Receive a single dose in a fasting state

All Listed Sponsors
lead

TaiGen Biotechnology Co., Ltd.

INDUSTRY

NCT03362853 - A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics | Biotech Hunter | Biotech Hunter